Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theorical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: an ecological approach.

Romero-López JP. et al, (2020), Journal of medical virology

Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination

Müller K. et al, (2020)

Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells-Comparison of Their Performances in ELISA.

Bagno FF. et al, (2020), Viruses, 12

Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon.

Soares IF. et al, (2020), Scientific reports, 10

The importance of the immunodominant CD8+ T cell epitope of Plasmodium berghei circumsporozoite protein in parasite- and vaccine-induced protection.

Gibbins MP. et al, (2020), Infection and immunity

Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates.

Kim YC. et al, (2020), Vaccines, 8

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines.

López-Camacho C. et al, (2020), Vaccines, 8

Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein.

Atcheson E. and Reyes-Sandoval A., (2020), Vaccine, 38, 4346 - 4354

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection.

Mann GS. et al, (2020), PLoS neglected tropical diseases, 14

Balanced immunity is key for a successful dengue vaccine.

Reyes-Sandoval A., (2020), The Lancet. Infectious diseases

COVID-19 vaccines: breaking record times to first-in-human trials.

Kim YC. et al, (2020), NPJ vaccines, 5

Production and Purification of Zika Virus NS1 Glycoprotein in HEK293 Cells.

Kim YC. et al, (2020), Methods in molecular biology (Clifton, N.J.), 2142, 93 - 102

Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention.

Blight J. et al, (2019), Vaccines, 7

A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease

Kroon Campos R. et al, (2019), Pathogens, 8, 231 - 231

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers.

López-Camacho C. et al, (2019), Pathogens (Basel, Switzerland), 8

The Dual Role of the Antibody Response Against the Flavivirus Non-structural Protein 1 (NS1) in Protection and Immuno-Pathogenesis

Reyes-Sandoval A. and Ludert JE., (2019), FRONTIERS IN IMMUNOLOGY, 10

Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria.

Milicic A. et al, (2019), Sci Rep, 9

Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico

Kim YC. et al, (2019), Viruses, 11, 407 - 407

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus.

López-Camacho C. et al, (2019), Viruses, 11

51 years in of Chikungunya clinical vaccine development: A historical perspective.

Reyes-Sandoval A., (2019), Hum Vaccin Immunother, 1 - 8

Load More

1
2
3
4
5

Include forthcoming?